Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.37 |
| ▸ | FDPS | P14324 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | LCK | P06239 | 1/20 | 0.36 |
| ▸ | PPARD | Q03181 | 1/20 | 0.36 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.36 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.36 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.34 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11355575 | 0.92 | GPR84 (0.42) | GPR84FFAR1FDPSMAPTLCK | |
| SCHEMBL9574955 | 0.90 | GPR84 (0.46) | GPR84FFAR1FDPSMAPTLCK | |
| SCHEMBL574763 | 0.88 | CHRM1 (0.33) | — | |
| SCHEMBL432120 | 0.88 | CHRM1 (0.33) | — | |
| SCHEMBL26611584 | 0.88 | CA2 (0.31) | GPR84FFAR1HSPD1BLMHSPE1 | |
| SCHEMBL141909 | 0.83 | GPR84 (0.39) | GPR84FFAR1FDPSMAPTLCK | |
| SCHEMBL31620705 | 0.83 | GPR84 (0.40) | GPR84FFAR1FDPSMAPTLCK | |
| SCHEMBL31212517 | 0.82 | GPR84 (0.42) | GPR84FFAR1FDPSMAPTLCK | |
| SCHEMBL29218960 | 0.82 | GPR84 (0.42) | GPR84FFAR1FDPSMAPTLCK | |
| SCHEMBL14632330 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8753686-B2 | Surface-treating agents, surface-treated powders, and cosmetics comprising the same | SHISEIDO CO., LTD. (JP) | 2014-06-17 | — | — | US | disclosed |
| US-20110280946-A1 | Surface-Treating Agents, Surface-Treated Powders, And Cosmetics Comprising The Same | SHISEIDO CO., LTD. (JP) | 2011-11-17 | — | — | US | disclosed |
| EP-2112179-B1 | Surface-treated powders, and cosmetics comprising the same | SHISEIDO CO LTD (JP) | 2011-04-27 | — | — | EP | disclosed |
| EP-1803750-B1 | USE OF A POLYMER FOR SURFACE-TREATING A POWDER | SHISEIDO CO LTD (JP) | 2009-12-09 | — | — | EP | disclosed |
| EP-2112179-A1 | Surface-treated powders, and cosmetics comprising the same | Shiseido Co., Ltd. (JP) | 2009-10-28 | — | — | EP | disclosed |
| US-20080081029-A1 | acrylic homopolymers or copolymers, that can provide excellent hydrophobicity to powders or cosmetics, and can improve its rinsability | SHISEIDO CO., LTD. (JP) | 2008-04-03 | — | — | US | disclosed |
| EP-1803750-A1 | SURFACE-TREATING AGENT, SURFACE-TREATED POWDER, AND COSMETIC PREPARATION CONTAINING SAME | Shiseido Company, Limited (JP) | 2007-07-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080081029-A1 | acrylic homopolymers or copolymers, that can provide excellent hydrophobicity to powders or cosmetics, and can improve its rinsability | CHRM1, H1-0, H1-2 | GPR84 604/4885FFAR1 420/4885FDPS 4481/4885 |
| US-20110280946-A1 | Surface-Treating Agents, Surface-Treated Powders, And Cosmetics Comprising The Same | CHRM1, H1-0, H1-2 | GPR84 538/4885FFAR1 267/4885FDPS 4832/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.